CDKN2A and uterine corpus leiomyoma: Examples include those linked to somatic BRCA2 mutations (79), smooth fibroids cases linked to ki-67, p53, and p16 (80), and cases where uterine leiomyomas treated with Ulipristal acetate led to the development of uLMS (81).